Cardiovascular Syst (CSII) 24.69 $CSII Cardiovascular

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 11:17 PM

Cardiovascular Syst (CSII) 24.69 $CSII

Cardiovascular Systems Launches the Take A Stand Against Amputation Program in Time for September Peripheral Artery Disease (PAD) Awareness Month
BusinessWire - Thu Sep 01, 7:00AM CDT
September marks Peripheral Artery Disease (PAD) Awareness Month. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), has launched a public awareness and patient advocacy program, Take A Stand Against Amputation, to provide education about the disease and treatment options.
CSII: 24.69 (+0.24)

Cardiovascular Systems (CSII) Catches Eye: Stock Up 5.6%
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 7:40AM CDT
Cardiovascular Systems Inc. (CSII) saw its shares almost 6% in the last trading session.
CSII: 24.69 (+0.24), GWPH: 82.73 (+0.45)

Cardiovascular Systems Names Scott Ward as CEO
BusinessWire - Tue Aug 16, 6:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today announced that, following a national search, it has named Scott R. Ward, 56, the company's new Chairman and Chief Executive Officer, effective immediately. Ward has been serving as Chairman since November 2014 and Interim President and Chief Executive Officer since November 2015. He joined CSI's board in 2013. Edward Brown, a member of CSI's board since 2009, has been appointed as CSI's Lead Independent Director.
CSII: 24.69 (+0.24)

Cardiovascular Systems Releases 30-Day Results from Liberty 360° Study in Late-Breaking Presentation at 2016 Amputation Prevention Symposium
BusinessWire - Thu Aug 11, 9:30AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today released procedural and 30-day results from its LIBERTY 360° study in a late-breaking presentation at the 2016 Amputation Prevention Symposium (AMP) in Chicago.
CSII: 24.69 (+0.24)

Cardiovascular Systems (CSII) Loss Narrows Y/Y in Q4
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:58AM CDT
Cardiovascular Systems' (CSII) fiscal fourth-quarter loss was narrower than the Zacks Consensus Estimate; the top line also comfortably surpassed the mark.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), CSII: 24.69 (+0.24), IDXX: 114.09 (+0.93)

Upgrade Alert for Cardiovascular Systems (CSII)
Comtex SmarTrend(R) - Fri Aug 05, 3:01AM CDT
Cardiovascular Systems (NASDAQ:CSII) was upgraded from Underperform to Neutral at BofA/Merrill today. The stock closed yesterday at $21.23 on volume of 1.2 million shares, above average daily volume of 344,000. Cardiovascular Systems (NASDAQ:CSII) defies analysts with a current price ($21.23) 8.3% above its average consensus price target of $19.46. Cardiovascular Systems shares have support at the 200-day moving average (MA) of $15.61 and additional support at the 50-day MA of $11.78.
CSII: 24.69 (+0.24)

Cardiovascular Systems Reports Fiscal 2016 Fourth-Quarter Financial Results
BusinessWire - Wed Aug 03, 3:16PM CDT
--Revenues of $48.5 million grew 9% from third quarter of fiscal 2016, and were similar to the prior year Coronary device revenues grew 20% from prior year
CSII: 24.69 (+0.24)

Medical Product Stocks Earnings Preview for Aug 3: BIO, CSII & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:35AM CDT
Medical has been a stand out performer so far in Q2.
MGNX: 29.64 (-0.41), INSY: 14.63 (+0.27), CSII: 24.69 (+0.24), BIO: 151.14 (+1.65), CNAT: 1.84 (-0.02)

Cardiovascular Systems Up 88.6% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri Jul 29, 12:13AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 5 months, Cardiovascular Systems has returned 88.61% as of today's recent price of $19.30.
CSII: 24.69 (+0.24)

Cardiovascular Systems Has Returned 66.0% Since SmarTrend Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 21, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 65.98% as of today's recent price of $16.98.
CSII: 24.69 (+0.24)

Cardiovascular Systems Shares Up 78.3% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 14, 12:12AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 78.30% as of today's recent price of $18.24.
CSII: 24.69 (+0.24)

FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility
PR Newswire - Fri Jun 10, 10:30AM CDT
Terumo Cardiovascular Systems (Terumo CVS) received notice from the U.S. Food and Drug Administration (FDA) that it has successfully completed the second and final phase of its work plan to remediate all products manufactured or distributed from Terumo's Ann Arbor, Michigan manufacturing facility, including Terumo® Advanced Perfusion System 1. As a result, all shipping restrictions, imposed as a term of its 2011 consent decree, are now lifted.
CSII: 24.69 (+0.24)

Cardiovascular Systems Up 70.3% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri May 27, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 70.28% as of today's recent price of $17.42.
CSII: 24.69 (+0.24)

44.0% Return Seen to Date on SmarTrend Cardiovascular Systems Call (CSII)
Comtex SmarTrend(R) - Fri May 20, 12:34AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 43.99% as of today's recent price of $14.73.
CSII: 24.69 (+0.24)

Cardiovascular Systems Shares Up 42.4% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Thu May 12, 1:03PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 42.42% as of today's recent price of $14.57.
CSII: 24.69 (+0.24)

Updated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc.
PR Newswire - Thu May 12, 12:07PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company"

(NASDAQ: CSII), concerning whether the board has breached its fiduciary duties to shareholders.
CSII: 24.69 (+0.24)

Cardiovascular (CSII) Narrows Loss in Q3, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:36AM CDT
Cardiovascular Systems Inc. (CSII) reported third-quarter fiscal 2016 adjusted net loss per share of 31 cents.
CAPR: 3.80 (+0.16), CSII: 24.69 (+0.24), BAX: 46.28 (+0.10), CRDC: 2.35 (-0.15)

Cardiovascular Systems Shares Final Three-Year ORBIT II Results at 2016 Society for Cardiovascular Angiography and Interventions Annual Meeting
BusinessWire - Thu May 05, 7:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
CSII: 24.69 (+0.24)

Shares of CSII Up 33.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 05, 12:54AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 33.63% as of today's recent price of $13.67.
CSII: 24.69 (+0.24)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Kentucky Power's Bold Plan to Boost Local Economy

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

KeyCorp Plans Redemption of Series E Preferred Stock

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Manhattan Associates Faces Investigation by KSF Law Firm

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

BIBIBOP Brings Good Vibes with OLIPOP Happy Hour

Boosting Midday Energy with BIBIBOP's New Promo Here we go, folks. BIBIBOP Asian Grill is dialing up the culinary energy just when you need it most. From November 16 to 22, during their Good Energy Happy Hour, they’re serving up a deal designed to pump some pep into your afternoon—free OLIPOP prebiotic soda with any regular bowl purchase. Just stroll into any of their...

FiEE Rockets to Profitability with 382% Revenue Surge

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...